+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07433712

Project REACH Telehealth Program at Syringe Service Sites to Support People Who Use Drugs

Led by University of Minnesota · Updated on 2026-05-19

121

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating Project REACH, a telehealth program at syringe service programs SSPs designed to improve access to HIV-related evidence-based interventions for people who use drugs, including those who inject them. The study aims to assess how feasible and acceptable this approach is, as well as gather preliminary data on its effectiveness. This trial is led by the University of Minnesota and focuses on supporting individuals affected by substance use through remote healthcare access. Participants will engage with Project REACH primarily through recruitment and enrollment at SSPs. During a 6-month pilot period, telehealth services will be offered on-site at these programs. After the intervention period, a subset of participants and SSP staff will take part in exit interviews to provide feedback on their experiences with the program. Throughout the study, researchers will monitor recruitment and retention rates, participants comfort with accessing telehealth, and the uptake of preventive and treatment measures such as pre-exposure prophylaxis PrEP and medications for opioid use disorder MOUD. Participants will be involved for the duration of the 6-month pilot, with assessments focused on engagement and service use, helping to inform future telehealth efforts at SSPs.

CONDITIONS

Brief Title

Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs

Research Team

K

Kumi Smith

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here